Moderna
MRNA
#211
Rank
โ‚น10.222 T
Marketcap
โ‚น25,264
Share price
5.83%
Change (1 day)
1,051.24%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -โ‚น281.93 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น2.21 Billion. In 2025 the company made an earning of -โ‚น259.03 Billion, an increase over its 2024 earnings that were of -โ‚น336.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น281.93 Billion8.84%
2025 -โ‚น259.03 Billion-23.03%
2024 -โ‚น336.51 Billion-8.22%
2023 -โ‚น366.66 Billion-140.65%
2022 โ‚น901.98 B-27.81%
2021 โ‚น1.249 T-1911.15%
2020 -โ‚น68.99 Billion44.7%
2019 -โ‚น47.68 Billion28.63%
2018 -โ‚น37.07 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.758 T-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.187 T-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น722.22 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น4.46 Billion-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.05 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น3.93 Billion-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น114.71 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-โ‚น14.98 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA